Ligand Pharmaceuticals Incorporated Cash Flow-to-Debt Ratio
Ligand Pharmaceuticals Incorporated cash flow-to-debt ratio. Ligand Pharmaceuticals Incorporated (LGND) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of $24.02 Million could theoretically repay 0% of its total liabilities ($1.22 Billion) in one year. Check earnings quality score of Ligand Pharmaceuticals Incorporated to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Ligand Pharmaceuticals Incorporated (1994–2025)
Cash flow-to-debt ratio of Ligand Pharmaceuticals Incorporated from 1994 to 2025. Historical debt coverage capacity for Ligand Pharmaceuticals Incorporated across 32 annual periods. Check LGND cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Ligand Pharmaceuticals Incorporated Cash Flow-to-Debt Ratio by Year (1994–2025)
Ligand Pharmaceuticals Incorporated cash flow-to-debt ratio by year from 1994 to 2025. Year-by-year debt coverage analysis for Ligand Pharmaceuticals Incorporated. For the full cash flow conversion analysis, see cash efficiency ratio of Ligand Pharmaceuticals Incorporated.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | $49.36 Million | $543.42 Million | ▼ -89.6% |
| 2024 | 0.87x | $97.05 Million | $111.33 Million | ▲ +51.7% |
| 2023 | 0.57x | $49.58 Million | $86.30 Million | ▼ -31.2% |
| 2022 | 0.83x | $137.85 Million | $165.18 Million | ▲ +404.6% |
| 2021 | 0.17x | $78.80 Million | $476.43 Million | ▲ +97.8% |
| 2020 | 0.08x | $54.59 Million | $652.76 Million | ▲ +307.4% |
| 2019 | -0.04x | $-29.34 Million | $727.68 Million | ▼ -114.5% |
| 2018 | 0.28x | $194.06 Million | $699.89 Million | ▼ -25.2% |
| 2017 | 0.37x | $93.57 Million | $252.37 Million | ▲ +35.8% |
| 2016 | 0.27x | $63.00 Million | $230.73 Million | ▲ +50.2% |
| 2015 | 0.18x | $41.73 Million | $229.54 Million | ▲ +106.5% |
| 2014 | 0.09x | $20.57 Million | $233.62 Million | ▼ -76.6% |
| 2013 | 0.38x | $20.69 Million | $55.10 Million | ▲ +18039.4% |
| 2012 | 0.00x | $161.00K | $77.78 Million | ▲ +120.1% |
| 2011 | -0.01x | $-1.17 Million | $113.70 Million | ▲ +96.9% |
| 2010 | -0.33x | $-27.07 Million | $82.55 Million | ▼ -6.7% |
| 2009 | -0.31x | $-33.80 Million | $109.95 Million | ▼ -171.0% |
| 2008 | -0.11x | $-20.62 Million | $181.81 Million | ▲ +83.3% |
| 2007 | -0.68x | $-97.73 Million | $144.16 Million | ▼ -46.2% |
| 2006 | -0.46x | $-138.52 Million | $298.70 Million | ▼ -2456.4% |
| 2005 | 0.02x | $8.37 Million | $425.04 Million | ▲ +39.5% |
| 2004 | 0.01x | $5.75 Million | $407.78 Million | ▲ +1087.2% |
| 2003 | 0.00x | $274.00K | $230.53 Million | ▲ +100.9% |
| 2002 | -0.13x | $-25.11 Million | $196.59 Million | ▼ -12.5% |
| 2001 | -0.11x | $-19.91 Million | $175.35 Million | ▲ +59.6% |
| 2000 | -0.28x | $-47.35 Million | $168.55 Million | ▲ +25.6% |
| 1999 | -0.38x | $-60.50 Million | $160.20 Million | ▲ +5.1% |
| 1998 | -0.40x | $-66.60 Million | $167.40 Million | ▼ -117.0% |
| 1997 | -0.18x | $-13.40 Million | $73.10 Million | ▲ +62.8% |
| 1996 | -0.49x | $-33.30 Million | $67.60 Million | ▲ +14.9% |
| 1995 | -0.58x | $-37.90 Million | $65.50 Million | ▲ +17.5% |
| 1994 | -0.70x | $-14.30 Million | $20.40 Million | — |